期刊文献+

血栓弹力图在肺癌患者凝血功能异常中的应用 被引量:12

Study on the application of thromboelastography in assessing coagulation status in patients with carcinoma of the lungs
下载PDF
导出
摘要 目的研究血栓弹力图(TEG)在肺癌患者凝血功能异常中的意义。方法对本院确诊为肺癌的273例患者在2015年5月-2016年5月住院治疗期间,进行TEG、凝血4项及静脉血管超声检查,根据有无血栓形成分为血栓组、无血栓组;正常体检人员18名设为对照组,并比较3组凝血指标的差异情况。结果 TEG检测显示R值降低,血栓组与无血栓组、对照组比较,差异均有统计学意义(P<0.05);其他检测项目比较无统计学意义(P>0.05)。结论肺癌患者的TEG检测中R值降低,显示其血液处于高凝状态,有并发血栓的风险。 Objective To investigate the role of thromboelastography(TEG) in assessing coagulation status in patients with carcinoma of the lungs.Methods TEG,routine coagulation tests and venous Doppler ultrasound were done to detect the coagulation status in 273 patients who were diagnosed with lung cancer in Henan Tumor Hospital from May 2015 to May2016.The patients were divided into two groups: group 1 was diagnosed with deep vein thrombosis and group 2 was not diagnosed with thrombosis,in addition to a control group consisting of non-lung cancer patients with normal lung function.The detection results were compared among the three groups.Results The difference of R values between group 1 and group 2,and group 1 and control demonstrated significant differences(P〈 0.05).No statistically significant difference was found in the other test parameters among the three groups(P〉0.05).Conclusion The R value in TEG may indicate hypercoagulability and predict the high risk for deep vein thrombosis formation in patients with lung cancer.
出处 《中国输血杂志》 北大核心 2017年第9期1059-1061,共3页 Chinese Journal of Blood Transfusion
关键词 血栓弹力图 肺癌 凝血四项 血栓 thromboelastography coagulation tests lung cancer vein thrombosis
  • 相关文献

参考文献8

二级参考文献82

  • 1邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:428
  • 2Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med, 2000, 160(6): 809-815.
  • 3Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol, 2007, 44(2): 62-69.
  • 4Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293(6): 715-722.
  • 5Chuang YM, Yu CJ. Clinical characteristics and outcomes of lung cancer with pulmonary embolism. Oncology, 2009, 77(2): 100-106.
  • 6Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.J Thromb Haemost, 2007, 5(3): 632-634.
  • 7Scarvelis D, Anderson J, Davis L, et al. Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions. Thromb Res, 2010, 125(2): 166-170.
  • 8Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6 Suppl): 381S-453S.
  • 9Zangari M, Fink LM, Elice F, et al. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol, 2009, 27(29): 4865 -4873.
  • 10Zhou X, Teegala S, Huen A, et al. Incidence and risk factors of venous thromboembolic events in lymphoma, Am J Med, 2010, 123(10): 935-941.

共引文献232

同被引文献88

引证文献12

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部